News
Les maladies rares mobilisent un fonds de 75 millions d'euros | Les...
www.lesechos.fr
Longtemps parents pauvres de l'industrie pharmaceutique, les maladies rares qui affectent peu de patients individuellement mais, collectivement, 7 à ...
AM-Pharma Raises €29.2M in Series D Financing
www.genengnews.com
Firm will advance human alkaline phosphatase for AKI from preclinical testing.
AM-Pharma raises €29.2M in series D financing | Science|Business
sciencebusiness.net
Joël Jean-Mairet of Ysios, Remi Droller of Kurma Life Sciences Partners and Klaus Breiner of BB Biotech Ventures will join and further ...
Event eevc semi final aarhus
www.techtour.com
High-Tech Gründerfonds Management GmbH. Michael Brandkamp. High-Tech Gründerfonds Management GmbH (Germany). Rémi Droller. KLS Partners ...
sortiert nach Relevanz / Datum